Dennis Phillip Andrew
SEC CIK 2089237 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBP | NovaBridge Biosciences | Chief Medical Off | 173.4K | — | $11.4K | 4 | 2026-06-17 | 2026-09-18 |
Most active insiders at NBP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hagler Mark Arnold | See Remarks | $577.3K | — |
| 2 | Cao Sean Wuxiong | See Remarks, Dir | — | $122.5K |
| 3 | Xu Cong Claire | SVP, Clinical Development | — | $20.4K |
| 4 | Dennis Phillip Andrew | Chief Medical Off | — | $11.4K |
| 5 | Lenz Robert A. | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-21 16:05 | 2026-09-17 | NBP | NovaBridge Biosciences | Dennis Phillip Andrew | Chief Medical Off | M - OptEx | — | +23.7K | 181.6K | +15% | — |
| D | 2026-09-21 16:05 | 2026-09-18 | NBP | NovaBridge Biosciences | Dennis Phillip Andrew | Chief Medical Off | S - Sale+OE | $0.71 | -8,209 | 173.4K | -5% | -$5,828 |
| D | 2026-06-22 17:23 | 2026-06-17 | NBP | NovaBridge Biosciences | Dennis Phillip Andrew | Chief Medical Off | M - OptEx | — | +23.7K | 166.4K | +17% | — |
| D | 2026-06-22 17:23 | 2026-06-18 | NBP | NovaBridge Biosciences | Dennis Phillip Andrew | Chief Medical Off | S - Sale+OE | $0.66 | -8,494 | 157.9K | -5% | -$5,606 |
Purchase Sale Sale after option exercise All abbreviations